
5 outlets · Left 1 · Center 2 · Right 2
Each wing's outermost outlet, headline quoted verbatim - framing shows clearest at the edges. Center outlets appear with every other headline below.
each line: one outlet's first article — above the track left · below right · across center
First reported by Townhall (Right); 5 outlets over 14h. The left followed 3h later.
Townhall · +3h Al Jazeera · +4h The Hill · +8h Fox News · +14h NewsNation
More than 90 lawsuits against GLP-1 companies claim rare eye condition resulted from diabetes and weight loss drugs.
Read at aljazeera.com →“The risk-benefit of these drugs are still really, really good,” Rutgers Associate Professor Chintan Dave said.
Read at newsnationnow.com →Patients say the pharmaceutical companies failed to warn them of a risk of a rare condition that causes vision loss.
Read at thehill.com →Hundreds of consumers allege GLP-1 drugs like Ozempic and Wegovy caused NAION, a rare eye stroke linked to sudden, often permanent vision loss.
Read at foxnews.com →Each blurb is the outlet's own feed summary, quoted unedited. Nothing here is generated.
5 articles, newest first · filter by side
Every headline that clustered into this story, newest first. Links go straight to the publisher - no article text is stored here, and the one image is an unmodified copy of the publisher's own thumbnail.